We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at ...

Avesta's approach involves working with patients' mental health providers to tailor treatments to individual needs.

Stifel has initiated Compass Pathways (NASDAQ:CMPS) with a buy rating saying that stakeholders are starting to agree there is ...

Jason Najum talks to Srinivas Rao, CEO of Atai Life Sciences, a biotech company focused on mental health and psychedelic compounds.

Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

Ketamine, a dissociative anesthetic, has carved itself a spot in the world of mental health care over the past two decades.

Elon Musk's chaotic appearance at CPAC on Thursday caused Google searches for the phrase "is Elon Musk on drugs" to spike the ...

After the rejection of Lykos Therapeutics’ MDMA-based PTSD treatment tempered excitement for psychedelic therapeutics, a ...

Ketamine can trigger symptoms similar to those of schizophrenia, but it isn’t known to cause the disorder itself. Ketamine is gaining attention for its potential to treat depression and other ...

The X-rated film star was referred to the facility in question on 27 January, 2024 to seek treatment for a 'ketamine addiction'. Advert According to a shocking lawsuit which has since been filed by ...

If esketamine seems familiar, that’s probably because it’s a component of ketamine. It was once popular as a party drug called Special K. Fortunately, Spravato underwent 31 clinical trials ...

A phase III evaluation, the largest of its kind to date for racemic ketamine-assisted therapy ... to Johnson & Johnson's data on its blockbuster Spravato drug, an esketamine-based treatment ...